Evaluation of serum haptoglobin levels in patients with adnexal masses.
Over a four-year period, serum haptoglobin was measured in 152 patients with adnexal masses in an attempt to discriminate between benign and malignant disease. When serum haptoglobin exceeded 150 mg/dl, malignancy could be identified with a sensitivity of 83% and a specificity of 84%. While the predictive value of a positive test is only 66%, the predictive value of a negative test is 93%, and this inexpensive test may be clinically useful. Stage, grade, and size of tumor did not correlate with serum haptoglobin levels.
Elg
S
S
Lee
R B
RB
Stones
C
C
Webber
P J
PJ
Benson
W L
WL
D000290:Adnexa Uteri; D005260:Female; D005833:Genital Neoplasms, Female / Q000097:blood*; D006242:Haptoglobins / Q000032:analysis*; D006801:Humans; D011237:Predictive Value of Tests
D006242:Haptoglobins